Indian Drugmakers Engineer Hep C Cocktails Impossible in WestBy and
New cocktails could help tackle hepatitis C in poor countries
Indian companies eyeing market for genotype 3 of hepatitis C
Drugmakers in India are hard at work engineering hepatitis C combination pills impossible in western nations due to patent protections.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.